Inventiva Pharma
Frédéric Cren has served as the Chief Executive Officer since co-founding Inventiva in 2011, and as the chairman of the board of directors since May 2016. Previously, he served as the General Manager of Research of Abbott Laboratories, a pharmaceutical company, from 2010 until 2012. Prior to Abbott, Mr. Cren held a number of roles at Solvay Pharmaceuticals, a pharmaceutical company, and at Laboratoires Fournier SA, a pharmaceutical company, prior to its acquisition by Solvay in 2005. Positions at Laboratories Fournier included: Vice-President Strategic Marketing and Vice-President U.S. Operations, as well as serving as a member of the Executive Committee. Positions at Solvay included: Head of Business Strategy and Portfolio and Senior Vice-President of the Research Division, as well as serving as a member of the Executive Committee. Mr. Cren began his career with Boston Consulting Group, where he worked from 1993 to 2002. He received a master’s degree in Business Administration from INSEAD, a master’s degree in International Relations from Johns Hopkins University and a bachelor’s degree in Economics from Paris IX Dauphiné University.
This person is not in any offices
Inventiva Pharma
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology.